Association between metabolic dysfunction‐associated steatotic liver disease and myosteatosis measured by computed tomography
Journal of Cachexia, Sarcopenia and Muscle · 2024-10 · 15 (5) · 1942-1952
DOI: 10.1002/jcsm.13543 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cachexia, Sarcopenia and Muscle, online erschienen am 16.07.2024. Verfasst von Myung Jin Kim und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Tomography, X-Ray Computed. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
In 2023, the concept of metabolic dysfunction‐associated steatotic liver disease (MASLD) was introduced as an alternative to non‐alcoholic fatty liver disease (NAFLD). We aimed to assess the quantity and quality of skeletal muscle using each of these diagnostic classifications.
Methods
This cross‐sectional study included 18 154 participants (11 551 [63.6%] men and 6603 [36.4%] women, mean age 53.0 ± 8.8). The participants were classified into four categories: neither steatotic liver disease (SLD), NAFLD only, MASLD only or both SLDs. An appendicular skeletal muscle mass adjusted for body mass index of
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
- Asan Diabetes Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
- Health Screening and Promotion Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
ORCID-Profile: Myung Jin Kim, Yun Kyung Cho, Woo Je Lee, Hong-Kyu Kim, Chang Hee Jung
Zitieren
APA
Kim, M. J., Cho, Y. K., Kim, E. H., Lee, M. J., Lee, W. J., Kim, H. K., & Jung, C. H. (2024). Association between metabolic dysfunction‐associated steatotic liver disease and myosteatosis measured by computed tomography. Journal of Cachexia, Sarcopenia and Muscle, 15(5), 1942-1952. https://doi.org/10.1002/jcsm.13543
Vancouver
Kim MJ, Cho YK, Kim EH, Lee MJ, Lee WJ, Kim HK, et al. Association between metabolic dysfunction‐associated steatotic liver disease and myosteatosis measured by computed tomography. Journal of Cachexia, Sarcopenia and Muscle. 2024;15(5):1942-1952. doi:10.1002/jcsm.13543
BibTeX
@article{Kim2024,
author = {Kim, Myung Jin and Cho, Yun Kyung and Kim, Eun Hee and Lee, Min Jung and Lee, Woo Je and Kim, Hong-Kyu and Jung, Chang Hee},
title = {Association between metabolic dysfunction‐associated steatotic liver disease and myosteatosis measured by computed tomography},
journal = {Journal of Cachexia, Sarcopenia and Muscle},
year = {2024},
volume = {15},
number = {5},
pages = {1942--1952},
doi = {10.1002/jcsm.13543}
}
EUVIMED